Beta-blockers for the treatment of problematic hemangiomas

Canadian Journal of Plastic Surgery

Volumn 21, Issue 1, 2013, Pages 23-28

  Sharma, Vishal K ^a   Fraulin, Frankie O G ^a,b   Dumestre, Danielle O ^c   Walker, Lori ^c   Harrop Robertson, A ^a,b  

^a Department of Surgery   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Beta blocker; Hemangioma; Indications; Propranolol; Side effects; Treatment efficacy

Indexed keywords

EID: 84877842450     PISSN: 11952199     EISSN: None     Source Type: Journal    
DOI: 10.1177/229255031302100103     Document Type: Article

References (39)

1. Mulliken JB, Young AE. Vascular birthmarks: Hemangiomas and Vascular Malformations. Philadelphia : WB Saunders, 1988:41-62.
2. Mousa W, Kues K, Haas E, et al. Successful treatment of a large hemangioma with propranolol. J Germ Soc Derm 2010;8:184-6.
3. Gampper TJ, Morgan RF. Vascular anomalies: Hemangiomas. Plast Reconstr Surg 2002;110:572-85.
4. Bruckner AL , Frieden IJ. Infantile hemangiomas. J Am Acad Dermatol 2006;55:671-82. (Pubitemid 44436645)
5. Christison-Lagay ER, Fishman SJ. Vascular anomalies. Surg Clin N Am 2006;86:393-s425.
6. Arneja JS, Gosainz AK . Vascular malformations. Plast Reconstr Surg 2008;121:195e-206e. (Pubitemid 351653250)
7. Leauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: Part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol 2011;25:1254-60.
8. Leauté-Labrèze C, de la Roque ED, Hubiche T, Boralevi F, Thambo J-B, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. (Pubitemid 351831393)
9. Itinteang T, Brasch HD, Tan ST , Day DJ. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg 2010;64:759-65.
10. Iaccarino G, Ciccarelli M, Soriento D, et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptors overexpression: A novel role for the endothelial adrenergic system. Circ Res 2005;97:1182-9.
11. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action. Br J Dermatol 2010;163:269-74.
12. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: Promise, peril, pathogenesis, Pediatr Dermatol 2009;26:642-4.
13. Sharma VK, Fraulin FOG, Harropz AR , McPhalen DF. The opportunities and obstacles in developing a vascular birthmark database for clinical and research use. Can J Plast Surg 2011;19:122-4.
14. Fraulin FOG, Flannigan RK, Sharma VK, et al. The epidemiological profile of the Vascular Birthmark Clinic at the Alberta Children's Hospital. Can J Plast Surg 2012;20:67-70.
15. Hong E, Fischer G. Propranolol for recalcitrant ulcerated hemangioma of infancy. Ped Dermatol 2012;29:64-67.
16. Bernabeau-Wittel J, Pereyra-Rodriguez JJ, Mantrana-Bermeja ME, et al. Propranolol for the treatment of severe hemangiomas of infancy: Results from a series of 28 patients. Actas Dermosifiliogr 2011;102:510-6.
17. Buckmiller LM, Munson PD, Dyamenahalli U, et al. Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center. Laryngoscope 2010;120:676-81.
18. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: A case series of 30 infants. Br J Dermatol 2010;162:46-8.
19. Qin ZP, Liu XJ, Li KL, et al. [Treatment of infantile hemangiomas with low-dose propranolol: Evaluation of short-term efficacy and safety] Zhonghua Yi Xue Za Zhi 2009;89:3130-4.
20. Fuchsmann C, Quintal M-C, Giguerre C, et al. Propranolol as firstline treatment of head and neck hemangiomas. Arch Otolaryngo Head Neck Surg 2011;137:471-8.
21. Schupp CJ, Kleber J-B, Gunther P, Holland-Cunz S. Propranolol therapy in 55 infants with infantile hemangioma: Dosage, duration, adverse effects, and outcome. Ped Dermatol 2011;28:640-4.
22. Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics 2009;124:423-31.
23. Haider KM, Pager DA, Neely DE, et al. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS 2010;14:251-6.
24. Claerhout I, Buijsrogge M, Delbeke P, et al. The use of propranolol in the treatment of periocular infantile haemangiomas: A review. Br J Ophthal 2011;95:1199-202.
25. Blatt J, Morrell DS, Buck S, et al. Beta-blockers for infantile hemangiomas: A single-institution experience. Clin Pediat 2011;50:757-63.
26. De Graaf M, Breur J, Raphael M, et al. Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants. J Am Acad Dermatol 2011;65:320-7.
27. Raphael M, de Graaf M, Breugem C, et al. Atenolol: A promising alternative to propranolol for the treatment of hemangiomas. J Am Acad Dermatol 2011;65:420-1.
28. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 2011;128:259-66.
29. Cushing SL, Boucek RJ, Manningz SC , et al. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas. Otolaryngol Head Neck Surg 2011;144:78-84.
30. Al Dhaybi R, Superstein R, Milet A, et al. Treatment of periocular infantile hemangiomas with propranolol: Case series of 18 children. Ophthalmology 2011;118:1184-8.
31. Schiestl C, Neuhaus K, Zoller S, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 2011;170:493-501.
32. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesth Surg 2011;64:445-51.
33. Missoi TG, Lueder GT, Gibertson K, Bayliss SJ. Oral propranolol for treatment of periocular infantile hemangiomas. Arch Ophthalmol 2011;129:899-903.
34. Bagazgoitia L, Torrelo A, Gutierrez JC, et al. Propranolol for infantile hemangiomas. Pediat Dermatol 2011;28:108-14.
35. Zvulunov A, McCuaig C, Frieden IJ, et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: A multicenter retrospective study. Ped Derm 2011;28:94-8.
36. George ME, Sharma V, Jacobson, et al. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004;140:963-9. (Pubitemid 39062647)
37. Baselga E. Past, present, and future of propranolol for hemangiomas of infancy. Actas Dermosifiliogr 2011;102:484-6.
38. Price CJ, Lattouf C, Baum B, et al. Propranolol vs corticosteroids for infantile hemangiomas: A multicenter retrospective analysis. Arch Dermatol 2011;147:1371-6.
39. Peridis S, Pilgrim G, Athanasopolous I, Parpounas K. A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Ped Otorhinolaryngol 2011;75:455-60.